Anesthesia in a patient with mucopolysaccharidosis type VI (Maroteaux–Lamy syndrome)

被引:0
|
作者
Soon Hak Suh
Ryu Okutani
Masato Nakasuji
Kazuo Nakata
机构
[1] Kansai Denryoku Hospital,Department of Anesthesiology
[2] Osaka City General Hospital and Children’s Hospital,Department of Anesthesiology
来源
Journal of Anesthesia | 2010年 / 24卷
关键词
Mucopolysaccharidosis; Maroteaux–Lamy syndrome; Difficult airway; Pediatric anesthesia;
D O I
暂无
中图分类号
学科分类号
摘要
We report a case of anesthesia during surgery to enlarge the foramen magnum in a pediatric patient with an extremely rare form of mucopolysaccharidosis type VI (Maroteaux–Lamy syndrome). Airway control was unexpectedly easy, and intraoperative anesthetic management with total intravenous anesthesia went smoothly. However, the disease is progressive, with no guarantee that future anesthetic management of this patient will remain easy. If repeated surgery is required, thorough testing should be conducted over time to assess both airway and systemic complications. Nevertheless, we found that safe anesthetic management of affected patients is possible with anesthetics currently used in a clinical setting.
引用
收藏
页码:945 / 948
页数:3
相关论文
共 50 条
  • [21] Growth charts for individuals with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
    Quartel, Adrian
    Graham, Sue
    Harmatz, Paul
    Lin, Ping
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (02) : S88 - S89
  • [22] DISTINCT BIOCHEMICAL DEFICIT IN MAROTEAUX-LAMY SYNDROME (MUCOPOLYSACCHARIDOSIS VI)
    BARTON, RW
    NEUFELD, EF
    JOURNAL OF PEDIATRICS, 1972, 80 (01): : 114 - +
  • [23] Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
    Harmatz, P
    Whitley, CB
    Waber, L
    Pais, R
    Steiner, R
    Plecko, B
    Kaplan, P
    Simon, J
    Butensky, E
    Hopwood, JJ
    JOURNAL OF PEDIATRICS, 2004, 144 (05): : 574 - 580
  • [24] Evaluation of galsulfase for the treatment of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
    Lourenco, Charles Marques
    Giugliani, Roberto
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (04): : 407 - 417
  • [25] Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) in the pre-Columbian culture of Colombia
    Pachajoa, Harry
    Armando Rodriguez, Carlos
    COLOMBIA MEDICA, 2014, 45 (02): : 85 - 87
  • [26] ANESTHESIA MANAGEMENT IN A PATIENT WITH MAROTEAUX-LAMY SYNDROME
    Tutuncu, Ayse Cigdem
    Kaya, Guner
    Altintas, Fatis
    Kendigelen, Pinar
    NOBEL MEDICUS, 2012, 8 (01): : 114 - 116
  • [27] Teaching NeuroImages: Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) in a previously undiagnosed infant
    Kwong, Yune
    Jaspan, Tim
    NEUROLOGY, 2012, 78 (08) : E53 - E53
  • [28] The oral manifestations of Maroteaux-Lamy syndrome (mucopolysaccharidosis VI):: A case report
    Alpöz, AR
    Çoker, M
    Çelen, E
    Ersin, NK
    Gökçen, D
    van Diggelenc, OP
    Huijmansc, JGM
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2006, 101 (05): : 632 - 637
  • [29] Macrophage Involvement in Mitral Valve Pathology in Mucopolysaccharidosis Type VI (Maroteaux-Lamy Syndrome)
    Brands, Marion
    Roelants, Jorine
    de Krijger, Ronald
    Bogers, Ad
    Reuser, Arnold
    van der Ploeg, Ans
    Helbing, Wim
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2013, 161 (10) : 2550 - 2553
  • [30] MAROTEAUX-LAMY MUCOPOLYSACCHARIDOSIS (TYPE-VI) AND ARYLSULFATASE B DEFICIENCY
    DIFERRAN.N
    SINGH, J
    DONNELLY, PV
    GNIOTSZU.J
    FEDERATION PROCEEDINGS, 1974, 33 (05) : 1520 - 1520